Click for best price
Arginase Deficiency Therapeutics Market Size, Share 2022
Argininemia, also called?arginase deficiency, is an autosomal recessive urea cycle disorder where adeficiency?of the enzyme?arginase?causes a buildup of arginine and ammonia in the blood.
This report contains market size and forecasts of Arginase Deficiency Therapeutics in Global, including the following market information:
Global Arginase Deficiency Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Arginase Deficiency Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Arginase Deficiency Therapeutics include Helsinn Healthcare, Novartis Pharmaceuticals, Horizo??n Pharma and Medicis Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Arginase Deficiency Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Arginase Deficiency Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Arginase Deficiency Therapeutics Market Segment Percentages, by Type, 2021 (%)
Oral
Injection
Global Arginase Deficiency Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Arginase Deficiency Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospital
Drugs Stores
Other
Global Arginase Deficiency Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Arginase Deficiency Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Arginase Deficiency Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Arginase Deficiency Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Helsinn Healthcare
Novartis Pharmaceuticals
Horizo??n Pharma
Medicis Pharmaceutical
| Report Attributes |
Report Details |
| Report Title |
Arginase Deficiency Therapeutics Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Arginase Deficiency Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Arginase Deficiency Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Arginase Deficiency Therapeutics Overall Market Size
2.1 Global Arginase Deficiency Therapeutics Market Size: 2021 VS 2028
2.2 Global Arginase Deficiency Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Arginase Deficiency Therapeutics Players in Global Market
3.2 Top Global Arginase Deficiency Therapeutics Companies Ranked by Revenue
3.3 Global Arginase Deficiency Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Arginase Deficiency Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Arginase Deficiency Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Arginase Deficiency Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Arginase Deficiency Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Arginase Deficiency Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Arginase Deficiency Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Oral
4.1.3 Injection
4.2 By Type - Global Arginase Deficiency Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Arginase Deficiency Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Arginase Deficiency Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Arginase Deficiency Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Arginase Deficiency Therapeutics Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Drugs Stores
5.1.4 Other
5.2 By Application - Global Arginase Deficiency Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Arginase Deficiency Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Arginase Deficiency Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Arginase Deficiency Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Arginase Deficiency Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Arginase Deficiency Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Arginase Deficiency Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Arginase Deficiency Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Arginase Deficiency Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Arginase Deficiency Therapeutics Revenue, 2017-2028
6.3.2 US Arginase Deficiency Therapeutics Market Size, 2017-2028
6.3.3 Canada Arginase Deficiency Therapeutics Market Size, 2017-2028
6.3.4 Mexico Arginase Deficiency Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Arginase Deficiency Therapeutics Revenue, 2017-2028
6.4.2 Germany Arginase Deficiency Therapeutics Market Size, 2017-2028
6.4.3 France Arginase Deficiency Therapeutics Market Size, 2017-2028
6.4.4 U.K. Arginase Deficiency Therapeutics Market Size, 2017-2028
6.4.5 Italy Arginase Deficiency Therapeutics Market Size, 2017-2028
6.4.6 Russia Arginase Deficiency Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Arginase Deficiency Therapeutics Market Size, 2017-2028
6.4.8 Benelux Arginase Deficiency Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Arginase Deficiency Therapeutics Revenue, 2017-2028
6.5.2 China Arginase Deficiency Therapeutics Market Size, 2017-2028
6.5.3 Japan Arginase Deficiency Therapeutics Market Size, 2017-2028
6.5.4 South Korea Arginase Deficiency Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Arginase Deficiency Therapeutics Market Size, 2017-2028
6.5.6 India Arginase Deficiency Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Arginase Deficiency Therapeutics Revenue, 2017-2028
6.6.2 Brazil Arginase Deficiency Therapeutics Market Size, 2017-2028
6.6.3 Argentina Arginase Deficiency Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Arginase Deficiency Therapeutics Revenue, 2017-2028
6.7.2 Turkey Arginase Deficiency Therapeutics Market Size, 2017-2028
6.7.3 Israel Arginase Deficiency Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Arginase Deficiency Therapeutics Market Size, 2017-2028
6.7.5 UAE Arginase Deficiency Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Helsinn Healthcare
7.1.1 Helsinn Healthcare Corporate Summary
7.1.2 Helsinn Healthcare Business Overview
7.1.3 Helsinn Healthcare Arginase Deficiency Therapeutics Major Product Offerings
7.1.4 Helsinn Healthcare Arginase Deficiency Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Helsinn Healthcare Key News
7.2 Novartis Pharmaceuticals
7.2.1 Novartis Pharmaceuticals Corporate Summary
7.2.2 Novartis Pharmaceuticals Business Overview
7.2.3 Novartis Pharmaceuticals Arginase Deficiency Therapeutics Major Product Offerings
7.2.4 Novartis Pharmaceuticals Arginase Deficiency Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Novartis Pharmaceuticals Key News
7.3 Horizo??n Pharma
7.3.1 Horizo??n Pharma Corporate Summary
7.3.2 Horizo??n Pharma Business Overview
7.3.3 Horizo??n Pharma Arginase Deficiency Therapeutics Major Product Offerings
7.3.4 Horizo??n Pharma Arginase Deficiency Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Horizo??n Pharma Key News
7.4 Medicis Pharmaceutical
7.4.1 Medicis Pharmaceutical Corporate Summary
7.4.2 Medicis Pharmaceutical Business Overview
7.4.3 Medicis Pharmaceutical Arginase Deficiency Therapeutics Major Product Offerings
7.4.4 Medicis Pharmaceutical Arginase Deficiency Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Medicis Pharmaceutical Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Arginase Deficiency Therapeutics Market Opportunities & Trends in Global Market
Table 2. Arginase Deficiency Therapeutics Market Drivers in Global Market
Table 3. Arginase Deficiency Therapeutics Market Restraints in Global Market
Table 4. Key Players of Arginase Deficiency Therapeutics in Global Market
Table 5. Top Arginase Deficiency Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Arginase Deficiency Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Arginase Deficiency Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Arginase Deficiency Therapeutics Product Type
Table 9. List of Global Tier 1 Arginase Deficiency Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Arginase Deficiency Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Arginase Deficiency Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Arginase Deficiency Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Arginase Deficiency Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Arginase Deficiency Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Arginase Deficiency Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Arginase Deficiency Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Helsinn Healthcare Corporate Summary
Table 31. Helsinn Healthcare Arginase Deficiency Therapeutics Product Offerings
Table 32. Helsinn Healthcare Arginase Deficiency Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Pharmaceuticals Corporate Summary
Table 34. Novartis Pharmaceuticals Arginase Deficiency Therapeutics Product Offerings
Table 35. Novartis Pharmaceuticals Arginase Deficiency Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Horizo??n Pharma Corporate Summary
Table 37. Horizo??n Pharma Arginase Deficiency Therapeutics Product Offerings
Table 38. Horizo??n Pharma Arginase Deficiency Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Medicis Pharmaceutical Corporate Summary
Table 40. Medicis Pharmaceutical Arginase Deficiency Therapeutics Product Offerings
Table 41. Medicis Pharmaceutical Arginase Deficiency Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Arginase Deficiency Therapeutics Segment by Type in 2021
Figure 2. Arginase Deficiency Therapeutics Segment by Application in 2021
Figure 3. Global Arginase Deficiency Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Arginase Deficiency Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Arginase Deficiency Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Arginase Deficiency Therapeutics Revenue in 2021
Figure 8. By Type - Global Arginase Deficiency Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Arginase Deficiency Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Arginase Deficiency Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Arginase Deficiency Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Arginase Deficiency Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Arginase Deficiency Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Arginase Deficiency Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Arginase Deficiency Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Arginase Deficiency Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Helsinn Healthcare Arginase Deficiency Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Pharmaceuticals Arginase Deficiency Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Horizo??n Pharma Arginase Deficiency Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Medicis Pharmaceutical Arginase Deficiency Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
